MALAT1 and hepatocellular carcinoma: In HCC, MALAT1 promotes cell proliferation, epithelial-mesenchymal transition (EMT), migration and sorafenib resistance in HCC cells (Fan et al., 2020), suggesting its diagnostic, prognostic, and therapeutic role in HCC.